Literature DB >> 24993468

Tumefactive multiple sclerosis and fingolimod.

Jesus Lovera1, Nicole Villemarette-Pittman2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24993468     DOI: 10.1016/j.jns.2014.06.022

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  2 in total

1.  Tumefactive demyelination presenting during bevacizumab treatment.

Authors:  Claire M Rice; David Rossiter; Janev Fehmi; James C Stevens; Shelley A Renowden; Nicki Cohen; Clare Bailey; Neil J Scolding
Journal:  BMJ Case Rep       Date:  2015-12-16

Review 2.  Neurological safety of fingolimod: An updated review.

Authors:  Fumihito Yoshii; Yusuke Moriya; Tomohide Ohnuki; Masafuchi Ryo; Wakoh Takahashi
Journal:  Clin Exp Neuroimmunol       Date:  2017-06-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.